Verona Pharma (VRNA) Insider Trading & Ownership → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free VRNA Stock Alerts $14.79 -0.16 (-1.07%) (As of 05/7/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Verona Pharma (NASDAQ:VRNA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.80%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$378,874.24Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$10.65 M Get VRNA Insider Trade Alerts Want to know when executives and insiders are buying or selling Verona Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRNA Insider Buying and Selling by Quarter Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Verona Pharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/3/2024Kathleen A RickardInsiderSell36,248$1.96$71,046.08 11/20/2023Martin EdwardsDirectorBuy33,736$1.84$62,074.24 11/6/2023David R EbsworthDirectorBuy160,000$1.98$316,800.00 11/3/2023Kathleen A RickardInsiderSell58,752$1.92$112,803.84 8/7/2023Claire PollGeneral CounselSell1,512$2.47$3,734.64 8/7/2023David ZaccardelliCEOSell8,616$2.47$21,281.52 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 8/7/2023Kathleen A RickardInsiderSell1,600$2.47$3,952.00 8/4/2023David ZaccardelliCEOSell150,000$2.50$375,000.00 8/3/2023Claire PollGeneral CounselSell20,608$2.54$52,344.32 8/3/2023Kathleen A RickardInsiderSell50,600$2.55$129,030.00 8/3/2023Mark W HahnCFOSell117,272$2.54$297,870.88 8/2/2023David ZaccardelliCEOSell73,704$2.59$190,893.36 8/1/2023Claire PollGeneral CounselSell18,608$2.68$49,869.44 8/1/2023Kathleen A RickardInsiderSell19,736$2.68$52,892.48 8/1/2023Mark W HahnCFOSell105,944$2.68$283,929.92 5/15/2023Orbimed Advisors LlcDirectorSell359,713$20.08$7,223,037.04 5/11/2023Orbimed Advisors LlcDirectorSell80,000$22.26$1,780,800.00 (Data available from 1/1/2013 forward) VRNA Insider Trading Activity - Frequently Asked Questions Who is on Verona Pharma's Insider Roster? The list of insiders at Verona Pharma includes Claire Poll, David R Ebsworth, David Zaccardelli, Kathleen A Rickard, Lisa Deschamps, Mark W Hahn, Martin Edwards, and Orbimed Advisors Llc. Learn more on insiders at VRNA. What percentage of Verona Pharma stock is owned by insiders? 4.80% of Verona Pharma stock is owned by insiders. Learn more on VRNA's insider holdings. Which Verona Pharma insiders have been buying company stock? The following insiders have purchased VRNA shares in the last 24 months: David R Ebsworth ($316,800.00), and Martin Edwards ($62,074.24). How much insider buying is happening at Verona Pharma? Insiders have purchased a total of 193,736 VRNA shares in the last 24 months for a total of $378,874.24 bought. Which Verona Pharma insiders have been selling company stock? The following insiders have sold VRNA shares in the last 24 months: Claire Poll ($1,352,598.48), David Zaccardelli ($5,215,786.24), Kathleen A Rickard ($896,095.12), Mark W Hahn ($2,823,990.72), and Orbimed Advisors Llc ($95,419,764.96). How much insider selling is happening at Verona Pharma? Insiders have sold a total of 8,772,905 Verona Pharma shares in the last 24 months for a total of $105,708,235.52 sold. More Insider Trading Tools from MarketBeat Related Companies: LGND Insider Selling GMTX Insider Selling PCRX Insider Selling IRWD Insider Selling COLL Insider Selling XNCR Insider Selling MIRM Insider Selling KNSA Insider Selling GYRE Insider Selling MORF Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:VRNA) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.